Michel Guipponi

Dr. Michel Guipponi


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2009 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Closed access
PDF file
MGMichel Guipponi
Michel Guipponi
SDSamuel Deutsch
Samuel Deutsch
KKKarine Kohler
Karine Kohler
NPNader Perroud
Nader Perroud
FGFrançois Le Gal
François Le Gal
AMAlain Malafosse
Alain Malafosse

17 May 2010 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Closed access
PDF file
NPNader Perroud
Nader Perroud
ENElizabeth Neidhart
Elizabeth Neidhart
BPBrice Petit
Brice Petit
MVMonique Vessaz
Monique Vessaz
TLTérèse Laforge
Térèse Laforge
MGMichel Guipponi
Michel Guipponi

1 January 2008 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Closed access
MGMichel Guipponi
Michel Guipponi
SAStylianos Emmanuel Antonarakis
Stylianos Emmanuel Antonarakis
HSHamish S Scott
Hamish S Scott
Recently, we and others have shown that mutations in TMPRSS3 were responsible for autosomal recessive non-syndromic hearing loss. TMPRSS3 is a member of the Type II Transmembrane Serine Protease (TTSP) family and encodes for a protease that also contains LDLRA (low-density lipoprotein receptor class A) and SRCR (scavenger receptor cysteine rich) domains. Fourteen pathogenic mutations, which occur not only in the catalytic domain but also in the LDLRA and SRCR domains, have been identified to date that cause the DFNB8/10 forms of deafness. In vitro experiments demonstrated that TMPRSS3 mutants were proteolytically inactive indicating that TMPRSS3 protease activity is critical for normal auditory function. However, how missense mutations in the LDLRA and SRCR domains affect the proteolytic activity of TMPRSS3 remains to be elucidated. Although the role of TMPRSS3 in the auditory system is currently not completely understood, it has been shown to regulate the activity of the ENaC sodium channel in vitro and could therefore participate in the regulation of sodium concentration in the cochlea. TMPRSS3 mutations are not a common cause of hereditary deafness, the elucidation of its function is nevertheless important for better understanding of hearing, and provide biological targets for therapeutic interventions.

28 June 2016 in Human Genomics
Verified
Journal Article
Open access
PDF file
SFS. Fokstuen
S. Fokstuen
PMP. Makrythanasis
P. Makrythanasis
EHE. Hammar
E. Hammar
MGMichel Guipponi
Michel Guipponi
ERE. Ranza
E. Ranza
SAS. E. Antonarakis
S. E. Antonarakis
In order to optimally integrate the use of high-throughput sequencing (HTS) as a tool in clinical diagnostics of likely monogenic disorders, we have created a multidisciplinary “Genome Clinic Task Force” at the University Hospitals of Geneva, which is composed of clinical and molecular geneticists, bioinformaticians, technicians, bioethicists, and a coordinator. We have implemented whole exome sequencing (WES) with subsequent targeted bioinformatics analysis of gene lists for specific disorders. Clinical cases of heterogeneous Mendelian disorders that could potentially benefit from HTS are presented and discussed during the sessions of the task force. Debate concerning the interpretation of identified variants and the content of the final report constitutes a major part of the task force’s work. Furthermore, issues related to bioethics, genetic counseling, quality control, and reimbursement are also addressed. This multidisciplinary task force has enabled us to create a platform for regular exchanges between all involved experts in order to deal with the multiple complex issues related to HTS in clinical practice and to continuously improve the diagnostic use of HTS. In addition, this task force was instrumental to formally approve the reimbursement of HTS for molecular diagnosis of Mendelian disorders in Switzerland.

20 August 2021 in Genes
Verified
Journal Article
Open access
PDF file
RHRoxane van Heurck
Roxane van Heurck
MCMaria Teresa Carminho-Rodrigues
Maria Teresa Carminho-Rodrigues
EREmmanuelle Ranza
Emmanuelle Ranza
CSCaterina Stafuzza
Caterina Stafuzza
LQLina Quteineh
Lina Quteineh
APAriane Paoloni-Giacobino
Ariane Paoloni-Giacobino
Purpose: Hearing loss is characterized by an extensive genetic heterogeneity and remains a common disorder in children. Molecular diagnosis is of particular benefit in children, and permits the early identification of clinically-unrecognized hearing loss syndromes, which permits effective clinical management and follow-up, including genetic counselling. Methods: We performed whole-exome sequencing with the analysis of a panel of 189 genes associated with hearing loss in a prospective cohort of 61 children and 9 adults presenting mainly with isolated hearing loss. Results: The overall diagnostic rate using exome sequencing was 47.2% (52.5% in children; 22% in adults). In children with confirmed molecular results, 17/32 (53.2%) showed autosomal recessive inheritance patterns, 14/32 (43.75%) showed an autosomal dominant condition, and one case had X-linked hearing loss. In adults, the two patients showed an autosomal dominant inheritance pattern. Among the 32 children, 17 (53.1%) had nonsyndromic hearing loss and 15 (46.7%) had syndromic hearing loss. One adult was diagnosed with syndromic hearing loss and one with nonsyndromic hearing loss. The most common causative genes were STRC (5 cases), GJB2 (3 cases), COL11A1 (3 cases), and ACTG1 (3 cases). Conclusions: Exome sequencing has a high diagnostic yield in children with hearing loss and can reveal a syndromic hearing loss form before other organs/systems become involved, allowing the surveillance of unrecognized present and/or future complications associated with these syndromes.

16 July 2016 in Human Genomics
Verified
Journal Article
Open access
PDF file
PMPeriklis Makrythanasis
Periklis Makrythanasis
MGMichel Guipponi
Michel Guipponi
FSFederico A. Santoni
Federico A. Santoni
MZMaha Zaki
Maha Zaki
MIMahmoud Y. Issa
Mahmoud Y. Issa
SAStylianos E. Antonarakis
Stylianos E. Antonarakis
The recent availability of whole-exome sequencing has opened new possibilities for the evaluation of individuals with genetically undiagnosed intellectual disability. We report two affected siblings, offspring of first-cousin parents, with intellectual disability, hypotonia, short stature, growth hormone deficiency, and delayed bone age. All members of the nuclear family were genotyped, and exome sequencing was performed in one of the affected individuals. We used an in-house algorithm (CATCH v1.1) that combines homozygosity mapping with exome sequencing results and provides a list of candidate variants. One identified novel homozygous missense variant in KALRN (NM_003947.4:c.3644C>A: p.(Thr1215Lys)) was predicted to be pathogenic by all pathogenicity prediction software used (SIFT, PolyPhen, Mutation Taster). KALRN encodes the protein kalirin, which is a GTP-exchange factor protein with a reported role in cytoskeletal remodeling and dendritic spine formation in neurons. It is known that mice with ablation of Kalrn exhibit age-dependent functional deficits and behavioral phenotypes. Exome sequencing provided initial evidence linking KALRN to monogenic intellectual disability in man, and we propose that KALRN is the causative gene for the autosomal recessive phenotype in this family.